Galenea to Receive $6 Million From The Stanley Medical Research Institute to Progress Pro-Cognitive Drug Discovery and Development Program
4/26/2012 7:50:02 AM
More...
|
Omeros Corporation Receives $3.1 Million Milestone Payment from The Stanley Medical Research Institute for Schizophrenia Program
1/28/2009 11:17:24 AM
More...
|
Memory Pharmaceuticals (MEMY) Announces Agreement With The Stanley Medical Research Institute For The Development Of MEM 1003 For Bipolar Disorder
12/20/2005 10:48:18 AM
More...
|
Repligen Corporation (RGEN) And The Stanley Medical Research Institute Expand Development Agreement For Uridine For Bipolar Depression
10/21/2005 12:20:31 PM
More...
|
Novasite Pharmaceuticals And The Stanley Medical Research Institute Announce Alliance To Discover Novel Allosteric Modulator Drugs For Schizophrenia
10/19/2005 5:12:22 PM
More...
|
Potomac Pharma Inc. Announces Investment From The Stanley Medical Research Institute
10/19/2005 5:11:02 PM
More...
|
Saegis Pharmaceuticals Receives $2 Million Investment From The Stanley Medical Research Institute
10/19/2005 5:09:49 PM
More...
|